Prevalence of human papillomavirus genotypes among women with cervical cancer in Ghana

Table 2 Distribution of specific HPV genotypes detected in cancerous cervical tissues, occurring either as single infections or alongside others in multiple-infections

HPV type	Overall, (%)^a (N = 230)	Multiple-infections (%)^b (N = 120)	Single infections (%)^c (N = 110)	Odds ratio (OR)	95 % CI
18	109 (47.4)	83 (68.6)	26 (23.9)	6.97^d	3.89–12.50
59	97 (42.2)	80 (66.1)	17 (15.6)	10.56^d	5.57–20.02
45	86 (37.4)	54 (44.6)	32 (29.4)	1.94^d	1.12–3.35
16	23 (10.0)	13 (10.7)	10 (9.2)	1.19	0.50–2.84
31	20 (8.7)	14 (11.6)	6 (5.5)	2.50	0.83–6.07
56	14 (6.1)	9 (7.4)	5 (4.6)	1.67	0.54–5.15
6_11	10 (4.3)	6 (5.0)	2 (1.8)	1.40	0.37–1.99
35	8 (3.5)	6 (5.0)	2 (1.8)	2.79	0.55–14.13
42	7 (3.0)	4 (3.3)	2 (1.8)	1.21	0.26–5.52
44	7 (3.0)	3 (2.5)	4 (3.7)	0.66	0.15–3.05
58	5 (2.2)	3 (2.5)	2 (1.8)	1.36	0.22–8.30
33	3 (1.3)	3 (2.5)	0 (0.0)	UD	UD
66	2 (0.9)	1 (0.8)	1 (0.9)	0.90	0.06–14.57
43	1 (0.4)	1 (0.8)	0 (0.0)	UD	UD
51	1 (0.4)	0 (0.0)	1 (0.9)	UD	UD

UD undeterminable, as a result of less than five detections of each HPV for each state of infection
OR = Measures the odds of the association between being positive for each type HPV and the state of multiple-infection
^apercentage of total infections
^bpercentage of total multiple-infections
^cpercentage of total single infections
^dSignificantly associated with multiple-infections because odds ratio is not = 1.0 and a 95 % CI does not overlapping 1.0

ISSN: 1750-9378